New Key Statistics Module, Z-Score and F-Score
NAS:LVTX Key Ratios
| Market Cap $ M | 69.40 |
| Enterprise Value $ M | -17.23 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 1.35 |
| Price/Sales | 10.09 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 6.00 |
| EPS (TTM) $ | -1.57 |
| Beneish M-Score | -2.59 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 0.42 |
| EV-to-EBITDA | 0.43 |
| PEG | -- |
| Shares Outstanding M | 26.29 |
| Net Margin (%) | -620.09 |
| Operating Margin % | -638.99 |
| Pre-tax Margin (%) | -615.97 |
| Quick Ratio | 6.62 |
| Current Ratio | 6.62 |
| ROA % (ttm) | -34.18 |
| ROE % (ttm) | -63.41 |
| ROIC % (ttm) | -392.99 |
| Dividend Yield % | -- |
| Altman Z-Score | -1.40 |
LVTX Number of Guru Trades
LVTX Volume of Guru Trades
Gurus Latest Trades with NAS:LVTX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:LVTX is held by these investors
Total 1
LAVA Therapeutics NV Insider Transactions
No Available Data
News about NAS:LVTX
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers